Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Antivir Ther. 2012 Oct 5;18(2):243–248. doi: 10.3851/IMP2420

Table 1.

Characteristics of the study subjects

Mean ± SE (unless otherwise noted)
Demographics
  Age (years) 47.5 ± 2.5
  Gender (male) 12/12 (100%)
Immune parameters
  Duration HIV (years) 14.1 ± 1.5
  Duration ART (years) 9.2 ± 1.7
    NRTI (years) 9.0 ± 1.6
    NNRTI (years) 1.7 ± 0.9
    PI (years) 7.7 ± 2.1
  NRTI
    current 11/12 (92%)
    past 1/12 (8%)
    never 0/12 (0%)
  NNRTI
    current 2/12 (17%)
    past 3/12 (25%)
    never 7/12 (58%)
  PI
    current 5/12 (42%)
    past 3/12 (25%)
    never 4/12 (33%)
  CD4 count (#/mm3) 536 ± 46
  viral load (undetectable) 12/12 (100%)
  TNF-α (pg/mL) 13 ± 3
Body composition parameters
  BMI (kg/m2) 23.7 ± 1.4
  iliac waist circumference (cm) 87 ± 3
  abdominal subcutaneous adipose tissue (cm) by CT 131 ± 24
  visceral adipose tissue (cm) by CT 100 ± 21
  arm fat (kg) by DXA 0.9 ± 0.1
  leg fat (kg) by DXA 1.7 ± 0.2
  fat percentage of extremities by DXA 16.5 ± 1.9 (range 8.2 – 27.9%)
Metabolic parameters
  Total cholesterol (mmol/l) 4.4 ± 0.2
  LDL cholesterol (mmol/l) 2.5 ± 0.2
  HDL cholesterol (mmol/l) 1.2 ± 0.1
  Triglycerides (mmol/l) 1.5 ± 0.3
  Fasting glucose (mmol/l) 4.6 ± 0.2
  HOMA-IR 0.8 ± 0.2 (range 0.1 – 3.1)